NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy
IntroductionTherapeutic antibodies have become a major strategy to treat oncologic diseases. For chronic lymphocytic leukemia, antibodies against CD20 are used to target and elicit cytotoxic responses against malignant B cells. However, efficacy is oft…